retatrutide research peptide Triple Agonist (GLP-1/GIP/GCG) Retatrutide 20mg / 30mg /

GIP has also been found to exert influence over other tissues such as bone, although its extraglycemic profile is quite limited and largely pre-clinical in nature compared to its much celebrated partner GLP-1 [13]

What exactly is microdosing

These results provide clues to neural mechanisms that support the development of GLP- 1 and GIP combination therapeutics for the treatment of obesity and DM [79]

doi: 10.1152/ajpgi.00024.2010 15 FehmannHCGkeRGkeB

If a patient is consistently losing a healthy amount of weight and feels well, the patients clinician may elect to establish the current dose as meeting the patients needs rather than force an increase for protocols sake

Is retatrutide better than Ozempic